 |  | 
September 25, 2012 | | BAD IDEA This is the perfect time for Romney to pivot back to the economy. Unfortunately for him, talking up his economic “plan” won’t do anything to fix his faltering campaign, writes The Daily Beast’s Michael Tomasky. POLITICS ASIDE President Obama will take the stage before the United Nations General Assembly Tuesday and make the declaration that the U.S. plans to stand firm in the face of anti-Americanism across the globe and assert its determination to keep Iran's nuclear ambitions at bay. While the election is clearly looming in the background of virtually anything the president does, Obama plans to keep his Republican opponent out of today's discussion at the U.N. That hasn't stopped Mitt Romney from criticizing the incumbent's foreign-policy leadership ahead of his big speech. "This is time for a president who will shape events in the Middle East, not just be merciful or be at the mercy of the events," Romney said Monday. HIGHLIGHTS Groundbreaking new research has discovered four distinct types of breast cancer, possibly opening the door to better treatment. The Daily Beast’s Lizzie Crocker on what you should know about the study one of its authors called “the breast-cancer equivalent of putting a man or woman on the moon.” VIOLENCE CONTINUES Bombs exploded at a Damascus school—a security site occupied by pro-government militias and security forces. The explosives are believed to have been planted by rebels. While a rebel group leader said that “at exactly 9:35 a.m., seven improvised devices were set off in two explosions to target a school used for weekly planning meetings between shabbiha militia and security officers,” Syria's state-run news agency has not reported the incident. “There were several officers present, and we are hoping they will be part of a large number of killed in this operation,” the rebel leader said. The Syrian capital has played host to daily fighting between rebels and government forces in the past 18 months since the revolt began. PRICEY MEDS Senior citizens should start searching now for a better Medicare prescription plan because the top 10 are about to see a major premium hike—of the double-digit variety. Avalere Health, a private health-care-analysis firm, released a report Monday predicting next year's premium surge. Officials for the Obama administration announced back in August that the basic drug-prescription premium for Medicare qualifiers will remain at $30 in 2013, but Avalere argues that while that number may be true for the entire market, it doesn’t take into account how price swings will affect individual customers. “The average senior is going to benefit by carefully scrutinizing their situation, because every year the market changes,” said Avalere’s president. | | 
GET The Cheat Sheet A speedy, smart summary of news and must-reads from across the Web. You'll love the featured original stories on politics, entertainment, and more from The Daily Beast's diverse group of contributors.  GET Culture Beast Weekly cultural recommendations from The Daily Beast.
| |
